Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/1989
08/09/1989EP0327360A2 Novel polypeptides and DNA encoding said polypeptides
08/09/1989EP0327305A2 Preparation of a recombinant subunit vaccine against pseudorabies infection
08/09/1989EP0327283A1 Method of reducing immunoglobulin E responses
08/09/1989EP0327180A2 Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
08/09/1989EP0327169A2 Immunotoxins from barley toxin
08/09/1989EP0327045A1 The antibiotic cammunocine, process for its preparation and its use as a medicine
08/09/1989EP0327000A2 Gene fragments coding for the variable region of an anti-HIV antibody, chimeric anti-HIV antibodies expressed using the same, and process for their preparation
08/09/1989EP0326799A2 Enzymatic process for synthesizing peptides
08/09/1989EP0326595A1 Peptides and antibodies that inhibit platelet adhesion
08/09/1989CN1034581A Antigen-antibody conjugate
08/08/1989US4855406 Oncogene-related peptides
08/08/1989US4855238 Recombinant gamma interferons having enhanced stability and methods therefor
08/08/1989US4855235 Monoclonal antibodies to human leukocyte antigens
08/08/1989US4855231 Regulatory region for heterologous gene expression in yeast
08/02/1989EP0326490A2 Synthetic peptides and mixtures thereof for detecting HIV antibodies
08/02/1989EP0326423A2 Vectors, compounds and methods for expression of a hum adenocarcinoma antigen
08/02/1989EP0326148A1 Human monoclonal antibody specific for Pseudomonas aeruginosa and hybrid cell lines
08/02/1989EP0326120A2 Human IFN-beta2/IL-6, its purification and uses
08/02/1989EP0326074A1 Haptene derivatives and haptene protein conjugates therefrom
08/02/1989EP0326046A2 Production of human epidermal growth factor
08/02/1989EP0326029A2 Antibiotic A 42867 derivative
08/02/1989EP0326013A2 Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto
08/02/1989EP0325986A2 Enzymatic hydrolysis of proteins
08/02/1989EP0325849A2 Retinoic acid receptor composition and method for identifying ligands
08/01/1989US4853220 Protein isolated from blood, process for preparing said protein, aantibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
08/01/1989US4853219 Angiogenesis inhibitors
07/1989
07/27/1989WO1989006798A1 Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore
07/27/1989WO1989006703A1 Diagnosis of retinoblastoma
07/27/1989WO1989006695A1 Cleaved dimers of mullerian inhibiting substance-like polypeptides
07/27/1989WO1989006692A1 Method of treating tumor cells by inhibiting growth factor receptor function
07/27/1989WO1989006690A1 Cloned genes encoding ig-cd4 fusion proteins and the use thereof
07/27/1989WO1989006657A1 Pulmonary surfactant protein and related polypeptide
07/27/1989WO1989006544A1 Heteroligating antibodies and therapeutic uses thereof
07/27/1989WO1989006543A1 Htlv-i peptide antigen and assay
07/27/1989DE3902157A1 Amphiregulin, verfahren zu dessen herstellung und pharmazeutische mittel Amphiregulin, process for its preparation and pharmaceutical compositions
07/26/1989EP0325489A1 Leu 23: Monoclonal antibody for monitoring leukocyte activation
07/26/1989EP0325474A2 Receptor protein for human B cell stimulating factor-2
07/26/1989EP0325262A2 Cloned genes encoding IG-CD4 fusion proteins and the use thereof
07/26/1989EP0325224A2 Methods of producing secreted receptor analogs and biologically active peptide dimers.
07/26/1989EP0324969A2 Method of measuring transferrin
07/26/1989EP0324867A1 Fc-binding protein and strain of producing the same
07/26/1989EP0324789A1 Methods of regulating metabolic stability of proteins
07/25/1989US4851512 With at least three of the first five amino acids deleted
07/25/1989US4851509 Immunostimulant oligopeptides
07/25/1989US4851395 Nitrogen-containing polysaccharide
07/25/1989US4851341 Forming protein-monoclonal antibody complex, isolation, dissociating
07/25/1989US4851340 Nontoxic to moths and flies
07/25/1989US4851332 Specific to surface antigens
07/19/1989EP0324712A2 Hirudin derivative
07/19/1989EP0324648A2 Recombinant eimeria tenella vaccines
07/19/1989EP0324647A2 Vector for the expression of fusion proteins and protein immunogens
07/19/1989EP0324625A1 Antigen antibody conjugate
07/19/1989EP0324556A2 Method to improve mRNA translation and use thereof for production of platelet factor-4
07/19/1989EP0324511A2 Methods for preparing proteins of altered structure
07/19/1989EP0324447A2 Means and process for producing a recombinant human interleukin-1 alpha polypeptide
07/19/1989EP0324274A1 Improved expression and secretion of heterologous proteins in yeast employing truncated alpha-factor leader sequences
07/19/1989EP0324162A1 Method of producing antibodies by genetic engineering
07/19/1989EP0324157A1 Gene fragment coding for a rabies virus glycoprotein and process for producing a rabies virus glycoprotein using the same
07/19/1989EP0324124A1 The cloning and sequencing of the gene which codes for a new pilinic subunit of Bordetella pertussis
07/19/1989EP0323997A1 Recombinant dna expression vectors
07/19/1989EP0166628B1 Process for the amplification of the expression of a determined gene in bacillus subtilis and strains obtained
07/18/1989US4849509 Hybridomas
07/18/1989US4849351 Multiple reading frame Escherichia coli expression vectors
07/18/1989US4849348 Post-transcriptional heme regulated heterologous gene expression in yeast using the leg hemoglobin leader sequence
07/18/1989CA1257541A1 Method for determination of hormones
07/13/1989WO1989006286A2 Probes for and methods of diagnosis for muscular dystrophy
07/13/1989WO1989006283A1 Novel plasmid vector with pectate lyase signal sequence
07/13/1989WO1989006279A1 Mutated subtilisin genes
07/13/1989WO1989006274A1 Cellulolytic, n2-fixing bacteria and use therefor
07/13/1989WO1989006242A1 Antibodies to a4 amyloid peptide
07/13/1989WO1989006241A1 Sorbin and peptide derivatives which increase aborption by the mucous membranes
07/13/1989WO1989006239A1 Elastase inhibiting polypeptides and process for their preparation by genetic recombination
07/13/1989WO1989006138A1 UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES
07/13/1989WO1989006135A1 Treatment of type 2 diabetes mellitus
07/13/1989WO1989006091A1 Cereal product
07/12/1989EP0323842A2 Method of purification of transforming growth factor-beta
07/12/1989EP0323838A2 Expression vector and method for controllable production of proteins in eukaryotes
07/12/1989EP0323806A1 Novel chimeric antibodies
07/12/1989EP0323805A2 Novel antibodies
07/12/1989EP0323802A2 Monoclonal antibodies against, and cell surface antigen of, lung carcinoma
07/12/1989EP0323489A1 Preparation of novel protein sweeteners
07/12/1989CN1033837A Method of incubating recombinant protein expression cells
07/11/1989US4847096 Process for treating whey proteins, and product obtained
07/11/1989US4847080 Genetic engineering
07/11/1989EP0304481A4 Monoclonal antibodies produced against glomerular proteoglycans.
07/11/1989CA1257211A1 Process for obtaining a fviii/vwf complex having therapeutic effects and product thus prepared
07/05/1989EP0323027A2 Monoclonal antibody purification process
07/05/1989EP0322990A1 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions
07/05/1989EP0322870A2 Synthetic plasmid, transformant, feline interferon gene and method for producing feline interferon
07/05/1989EP0322712A2 DNA sequences specific for malaria, their expression products and applications thereof
07/05/1989EP0322533A1 Bordetella pertussis toxin with altered toxicity
07/05/1989CN1033646A Microorganism having low acetate forming capability and process for production of useful substrate using same
07/04/1989US4845197 Monoclonal antibodies and methods for fungal pathogen detection
07/04/1989US4845194 Adsorption on styrene-divinylbenzene resin
07/04/1989US4845076 Antiinflammatory agent
07/04/1989US4845032 Dissolving in guanidine hydrochloride, precipitation, chromatography
07/04/1989US4845026 Medical diagnosis and monitoring
07/04/1989CA1256814A1 Method for producing interferons
07/04/1989CA1256795A1 Anti-idiotype antibodies induced by synthetic polypeptides
06/1989
06/29/1989WO1989005857A1 A METHOD OF SIMULTANEOUSLY PRODUCING A LARGE NUMBER OF Leu17-VIP-ANALOGS AND NEW Leu17-VIP-ANALOGS